Skip to main content
Advances in Biochemistry and Biotechnology Vol. 2

Advances in Biochemistry and Biotechnology Vol. 2

By Chiranjib Chakraborty, Biplab Sarkar

Published by Astral International Pvt Ltd

English 355 pages 2021 ISBN 9789351303091
Estimated reading time: 6 h 31 min
PDF

About this book

"This book throws light on some of the upcoming research and contributed fields which have been nourished by a group of talented Indian scientists. This volume puts a specialized focus on “Aquaculture and Animal Biotechnology” as these sector exhibited a quantum elevation in last decade. This book contains chapters such as application of bioactive peptides derived from fish waste, oilgae technology to aquaculture, nanotoxicity, innate and humoralimmunity, plant derived anticancer drugs, HIV, prevention of tuberculosis, miRNA as cancer marker, synthetic biology, utility of silver nanoparticles, cell free DNA, point care testing, kisspeptin in fish. This book will add immense value of the researchers, postgraduate and undergraduate students who would like to replenish themselves by acquiring latest information on biotechnology and biochemistry."

Availability

Advances in Biochemistry and Biotechnology Vol. 2 is available as PDF at 1 online bookshop.

Language
English
Share

Frequently asked questions

In what formats is Advances in Biochemistry and Biotechnology Vol. 2 available?
Advances in Biochemistry and Biotechnology Vol. 2 is available as PDF at 1 online bookshop.
Where can I buy Advances in Biochemistry and Biotechnology Vol. 2?
You can buy Advances in Biochemistry and Biotechnology Vol. 2 at Catademic. Compare every option in the list on this page.
How long does it take to read Advances in Biochemistry and Biotechnology Vol. 2?
At an average reading pace, Advances in Biochemistry and Biotechnology Vol. 2 takes about 6 h 31 min to read (355 pages).

Ratings & reviews

No ratings yet. Be the first to review this book.

Sign in to rate and review this book.

Comments

Sign in to join the conversation.

No comments yet.